News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Cybin Gears Up for GMP Manufacturing of CYB003 Capsules for Phase 3 Study
Friday, August 18, 2023Cybin Inc NYSE American CYBN NEO CYBN has revealed its initiation of preparations for producing a capsule variant of CYB their exclusive deuterated psilocybin analog This advancement marks a significant stride in the companys mission to transform men...
Tetra Pharm Technologies Launches Advanced Facility for Research, Manufacturing, and Production
Thursday, August 17, 2023Tetra Pharm Technologies a biotech company based in Denmark has recently completed its purposebuilt headquarters as part of its longterm growth strategy
Sparrow Pharmaceuticals Introduces Open-label Extension in RESCUE Phase 2 Trial of SPI-62 for ACTH-dependent Cushing’s Syndrome, Enrolling First Patient
Thursday, August 17, 2023Sparrow Pharmaceuticals has made a noteworthy announcement regarding its progress in tackling Cushings syndrome a challenging medical condition
Wugen Commences Phase 1 Clinical Trial for WU-NK-101: Innovative Allogeneic Memory Natural Killer (NK) Cell Therapy Aimed at Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients
Wednesday, August 16, 2023Wugen a biotech firm in the clinical development stage has initiated the dosing of patients in the Phase clinical trial for WUNK This innovative therapy aims to treat patients suffering from relapsed or refractory acute myelogenous leukemia AML
PDS Biotech Submits Phase 3 Protocol to FDA for Initiation of VERSATILE-003 Clinical Trial
Tuesday, August 15, 2023PDS Biotechnology Corporation a company engaged in clinicalstage immunotherapy research has recently put forward updated documentation to the US Food and Drug Administration FDA
Novartis Successfully Concludes Acquisition of Chinook Therapeutics
Monday, August 14, 2023Novartis has successfully concluded its acquisition of Chinook Therapeutics Inc a biopharmaceutical company headquartered in Seattle WA The acquisition valued at a potential USD billion is aligned with Novartis strategic focus on advancing precision...
Immatics Launches Phase 1/2 Clinical Trial to Evaluate IMA402, a Bispecific PRAME TCR, in Patients With Late-stage Solid Tumors
Friday, August 11, 2023Immatics NV NASDAQ IMTX has announced the commencement of a Phase clinical trial for its novel Bispecific T cell Engaging Receptor TCER IMA representing a significant step in the development of T cellredirecting cancer immunotherapies
Sosei Heptares and Cancer Research UK Have Initiated a Phase I/IIa Trial, Marking the Administration of the First Dose of the Cancer Immunotherapy Drug HTL0039732
Friday, August 11, 2023Sosei Group Corporation TSE and Cancer Research UK have jointly initiated a Phase IIIa clinical trial to assess a novel cancer immunotherapy drug known as HTL
Alzecure Announces Positive Outcomes From Phase I Clinical Trial of NeuroRestore ACD856 for Alzheimer's Disease
Thursday, August 10, 2023AlzeCure Pharma AB publ FN STO ALZCUR is a pharmaceutical company dedicated to the development of small molecule candidate drugs targeting disorders of the central nervous system
Pliant Therapeutics Introduces the BEACON-IPF Phase 2b Clinical Trial to Evaluate Bexotegrast's Potential in Treating Idiopathic Pulmonary Fibrosis
Thursday, August 10, 2023Pliant Therapeutics Inc a biotechnology company listed on Nasdaq under the symbol PLRX has announced the initiation of a Phase b clinical trial named BEACONIPF
